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Nicotinic receptors mediate stress-nicotine detrimental
interplay via dopamine cells’ activity
C Morel1,2,3,4,12, SP Fernandez5,6,12, F Pantouli7, FJ Meye2,8, F Marti1,2, S Tolu1,2, S Parnaudeau2,9, H Marie5,6, F Tronche2,9, U Maskos10,
M Moretti11, C Gotti11, M-H Han3,4, A Bailey7, M Mameli2,8, J Barik5,6,12 and P Faure1,2,12
Epidemiological studies report strong association between mood disorders and tobacco addiction. This high comorbidity requires
adequate treatment but the underlying mechanisms are unknown. We demonstrate that nicotine exposure, independent of drug
withdrawal effects, increases stress sensitivity, a major risk factor in mood disorders. Nicotine and stress concur to induce
long-lasting cellular adaptations within the dopamine (DA) system. This interplay is underpinned by marked remodeling of nicotinic
systems, causing increased ventral tegmental area (VTA) DA neurons’ activity and stress-related behaviors, such as social aversion.
Blocking β2 or α7 nicotinic acetylcholine receptors (nAChRs) prevents, respectively, the development and the expression of social
stress-induced neuroadaptations; conversely, facilitating α7 nAChRs activation speciﬁcally in the VTA promotes stress-induced
cellular and behavioral maladaptations. Our work unravels a complex nicotine-stress bidirectional interplay and identiﬁes
α7 nAChRs as a promising therapeutic target for stress-related psychiatric disorders.
Molecular Psychiatry advance online publication, 25 July 2017; doi:10.1038/mp.2017.145
INTRODUCTION
Psychiatric disorders, including drug addiction and depression,
impose an alarming burden on society.1–5 Tobacco use is the
leading cause of preventable death in developed countries. Yet,
most smokers who wish to quit smoking encounter severe
emotional and physical disturbances during drug withdrawal and
only a small percentage succeed. These emotional manifestations
include irritability, increased anxiety and depressed mood. The
relation between nicotine and depressive symptoms is complex.
Nicotine dependence increases more than threefold the vulner-
ability to develop depression.6,7 Conversely, depression symptoms
are heavy determinants of smoking initiation, maintenance and
cessation. For example, depression is associated with increased
risk for smoking initiation8 and the appearance of early mental
complications markedly increases the risk of later tobacco
abuse.9,10 In addition, more severe drug withdrawal episodes
have been reported in people with a history of depression, which
impedes smoking cessation. This indicates a link between nicotine
exposure and stress-related mood disorders.
These epidemiological and clinical data argue for a mutual
maintenance pattern wherein each illness perpetuates the other.
When two pathologies occur, simultaneously or sequentially, in
the same person, they are described as comorbid. In addition to
time correlation, comorbidity also implies interactions, as each
disorder increases the course and prognosis of the other
simultaneously.10 A major ﬁnding in psychopathology research
is that comorbidity is the rule rather than the exception. However,
why tobacco addiction and mood disorders often co-occur
represents a major conundrum for neuroscientists. Importantly,
as comorbid disorders often lack adequate treatment and are
mostly associated with poor prognosis, this bidirectional relation-
ship highlights the outdated strategy to treat each disease
separately.
This intertwined, but at present unclear, relationship may arise
from shared neuronal circuit adaptations. Despite their high
heterogeneity with respect to genetic predisposing factors and
behavioral manifestations of the symptoms, the above-mentioned
pathologies involve inﬂuences over dopaminergic circuits. Neuro-
nal nicotinic acetylcholine receptors (nAChRs) are key modulators
of midbrain dopamine (DA) cell activity.11 The activation of
nAChRs within the ventral tegmental area (VTA) by nicotine
encodes tobacco’s primary reinforcing properties.5,12–14 Nicotine,
in the absence of tobacco, is sufﬁcient to sustain self-
administration15 and produce reward in a conditioned place
preference paradigm.16 Nicotine’s action requires numerous
nAChRs subtypes segregated into high-afﬁnity heteromeric
nAChRs containing the β2 subunit (β2*) and low-afﬁnity homo-
meric α7 nAChRs.17 They determine the sensitivity of the reward
system to a minimum dose of nicotine necessary for VTA DA cell
activation and thus nicotine reinforcement.18 VTA nAChRs
subtypes are present on GABA and DA neurons, as well as on
excitatory inputs, which results in a ﬁne tuning of DA neuronal
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activity.11,12 Preclinical and clinical studies implicate both
high- and low-afﬁnity nAChRs in stress-induced pathologies. For
example, changes in nAChRs availability have been observed in
patients suffering from post-traumatic stress disorders or
depression.19–21
Chronic social defeat stress (SD) parses the enduring behavioral
abnormalities induced by stress and is believed to capture
features of depressive-like states.22 SD triggers an increase in DA
VTA neuronal activity23 that drives social avoidance. DA cells
exhibit two distinct patterns of in vivo activity—a low-frequency
tonic ﬁring and a high-frequency phasic ﬁring—with the
possibility of switching amongst these modes. This mode switch-
ing is associated with reward-related behaviors and has been
suggested to promote alertness in cases of threatening situations
as observed after SD. Increased DA neuron activity is a prerequisite
for the subsequent behavioral manifestations of stress
outcomes.24–27 Indeed, pharmacological or optogenetic inhibition
of VTA DA neurons promotes therapeutic-like effects as it reverses
SD-induced social aversion and anhedonia.24,25
Thus, VTA DA neurons are at a crossroad of nicotine’s
reinforcing effects and social stress-induced aversion. We
hypothesized that nAChRs could be a pivotal molecular target,
which would orchestrate the detrimental stress-nicotine interplay
at the cellular and behavioral levels. To tackle this issue, we
combined electrophysiology, pharmacology and radioligand
binding approaches, as well as behavioral readouts in wild-type
(WT) and nAChRs mutant mice. We demonstrate a bidirectional
interplay between stress and nicotine exposure, which requires
modulation of VTA DA neurons activity via α7 nAChRs.
MATERIALS AND METHODS
Further details regarding reagents, mice and procedures can be found in
the Supplementary Information section.
Animals
Mice were housed under standard animal housing conditions.
SD stress paradigms
The chronic SD stress paradigm was performed as described in Barik
et al.24 Social interaction was performed 24 h after the last defeat (day 11).
The substhreshold SD (SubSD) paradigm was adapted from Chaudhury
et al.25 Animals were individually introduced into a CD1 cage for 2 min of
SD. The experimental and the CD1 mice were maintained separated
through a partition for 20 min and then returned for 90 min to their home
cage. The SD was repeated one time and mice were assessed in the social
interaction test ~ 24 h later as described for the SD paradigm.
In vivo and in vitro electrophysiological recordings
Single-unit extracellular recordings of VTA DA cells were performed in
anesthetized mice11 on day 11 for SD or on day 2 for SubSD. Nicotine
injections were performed into the saphenous vein (intravenous). For
in vitro patch-clamp experiment, mice were anesthetized for slice
preparation on day 11 for SD or on day 2 for SubSD.
Pharmacological treatments
For chronic oral nicotine administration, mice were exposed to a gradually
increasing dose of nicotine (50–200 μg ml− 1) for a total of 19 days,
submitted to SubSD and tested for social interaction without drug
withdrawal. Methyllycaconitine (6 mg kg− 1) and dihydro-β-erythroidine
(1 mg kg− 1) were administered intraperitoneally 15 min before each
defeat session or before the target condition. PNU-120596 (1 mg kg− 1,
intraperitoneally) was administered 15 min before each defeat session of
the SubSD paradigm (that is, two injections, Figure 4d), whereas nicotine
(0.5 mg kg− 1, free base, intraperitoneally) was administered right after
each SD session. Mice were killed 24 h after for in vitro electrophysiological
recordings.
Binding
WT mice were submitted to SD, tested for social interaction and brains
from naive and stressed mice were snap frozen. For autoradiography,
brains were processed as described in Metaxas et al.28 For ligand binding,
P2 fractions were prepared from dissected VTA samples to perform
[3H]-Hemicholinium, [3H]-epibatidine and [125I]-α-Bungarotoxin binding.
Local VTA drug administration
Mice received an acute local injection of PNU-120596 (10 μM) and were
then submitted to SubSD. After 20 min spent in the cage of the CD1 mouse
with the partition in place, mice went directly through a second round of
defeat. For local nicotine administration, mice were submitted to SubSD.
Immediately after the ﬁrst session of SD, nicotine (100 ng per site) was
infused in the VTA, whereas mice were still facing the CD1 mouse through
the partition preventing physical contacts. Nicotine-injected mice
remained facing the CD1 for another 11 min before entering the second
defeat session. After administration, mice were then returned to their
home cage and tested for social interaction 24 h later.
RESULTS
To determine whether SD impacts nicotinic systems in the VTA,
mice were exposed to 10 days of SD (Figure 1a) and behavioral
outcomes and cellular adaptations monitored. Expectedly, defeated
(SD) WT mice displayed a marked social avoidance (Figure 1a)
associated with an increased discharge frequency and bursting
activity of VTA DA neurons (Figure 1b and Supplementary
Figure S1a). In addition, using in vitro patch-clamp recordings,
we observed that VTA DA neurons of defeated mice had an
increase in AMPA.R/NMDA.R ratio (Figure 1c), which is likely to
alter their output ﬁring. These cellular adaptations may have
relevance for nicotine actions on the DA system. To test this
hypothesis, we measured DA neuron responses to intravenous
nicotine administration in vivo. In naive mice (NoSD), a single
intravenous injection of 30 μg kg− 1 of nicotine,11,18 enhanced the
ﬁring and bursting activities of VTA DA cells (Figure 1d and
Supplementary Figure S1b–g). In striking contrast, defeated mice
exhibited a virtually abolished response to nicotine evidenced by
a lack of signiﬁcant variation from baseline of ﬁring and bursting
patterns of DA neurons (Figure 1d and Supplementary Figure
S1b–g). This shows that social stress profoundly remodels VTA
nicotinic systems. The ability of systemic nicotine to excite VTA DA
neurons in naive conditions requires the activation of VTA nAChRs
located on both GABA and DA neurons.11 Therefore, changes in
nAChRs expression could explain a blunted nicotine response in
SD conditions. Extensive brain mapping of α-bungarotoxin and
epibatidine binding sites by autoradiography revealed no global
alteration of α7 or β2* nAChRs numbers after SD, respectively
(Supplementary Figures S2 and S3). Nonetheless, we next per-
formed binding assays on VTA-dissected synaptic fractions from
naive and SD mice, and we observed a modest, but signiﬁcant
increase in epibatidine, but not α-bungarotoxin, binding sites
(Figure 1e). We hypothesized that the upregulation of epibatidine-
sentitive β2* nAChR-binding sites is a result of prolonged
exposure to the endogenous agonist acetycholine, and subse-
quent desensitization processes. We performed [3H]hemicholi-
nium binding to quantify the density of choline transporters,
which can be used as an index of endogenous cholinergic
transmission. We observed a signiﬁcant upregulation of choline
transporter numbers following SD (Figure 1e). This result illustrates
an enhanced cholinergic tone in the VTA after SD, as suggested in
human depressed subjects.20
Hence, SD alters the spontaneous activity of DA neurons, their
sensitivity to nicotine and increases the cholinergic tone in the
VTA. If SD and nicotine29 induce similar alterations within the DA
system, then nAChRs may be important mediators of these
enduring changes and a promising therapeutic target. Brain α7
and β2* nAChRs constitute most of binding sites for nicotine, and
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these receptors can functionally compensate each other. There-
fore, we ﬁrst took a global approach and used α7β2 nAChRs
double knockout mice that were exposed to SD to assess
behavioral and cellular adaptations. Unlike defeated WT mice,
defeated α7β2 nAChRs knockout mice did not display social
aversion (Figure 2a), nor the expected increase in DA neurons
activity (Figure 2b and Supplementary Figure S4a). As expected,
acute intravenous nicotine failed to excite DA VTA neurons in both
naive and defeated α7β2 nAChRs knockout mice (Figure 2c). In
order to dissect the individual contribution of nAChRs subtypes to
this effect, we next used pharmacological tools in WT mice. To
address the role of α7 or β2* nAChRs in the development phase of
SD-induced social avoidance and its underlying neuroadaptations
during the 10 days of the SD paradigm, WT mice were chronically
treated with systemic injections of saline or speciﬁc nAChRs
antagonists (Figure 2d), 15 min before each daily defeat exposure.
On day 11, the social interaction test was performed in a drug-free
condition. Chronic treatment with dihydro-β-erythroidine, a
selective β2* nAChRs antagonist, reversed the social avoidance
behavior, whereas the chronic administration of methyllycaconi-
tine did not (Figure 2d). To further examine the contribution of α7
or β2* nAChRs in the expression of social avoidance, naive and SD
mice were only acutely challenged with saline or a speciﬁc nAChRs
antagonist 15 min before the social interaction test (Figure 2e). In
striking contrast with the development phase, acute administra-
tion of methyllycaconitine, that is devoid of locomotor effect
(Supplementary Figure S5a), prevented SD-induced social aver-
sion, whereas dihydro-β-erythroidine did not reverse stress effects
but rather seemed to exacerbate it (Figure 2e). This indicates that
α7 and β2* nAChRs have a dual pivotal role in the development
and expression of stress-induced social aversion.
Thus, the cellular dysregulations of the DA system by SD, which
lead to behavioral maladaptations, require the biological substrate
of nicotine. If stress hijacks the nicotinic system, then nicotine
itself, via its action on VTA nAChRs, may be a risk factor for stress
outcomes by altering the ﬁne-tuning of DA cells activity. There-
fore, nicotine exposure would be expected to increase the
sensitivity of the DA system to a moderate social stress. To model
Figure 1. Behavioral and cellular interplay between social stress and nicotine responses in naive (no social defeat, NoSD) and defeated wild-
type (WT) mice (social defeat, SD). (a) Schematic of the chronic SD paradigm (left). Decreased social interaction in SD mice compared to NoSD
mice (right). (b) Firing rate (left panel) and percentage of spikes within bursts (%SWB; right panel) of ventral tegmental area (VTA) dopamine
(DA) cells recorded in vivo. (Inset) sample in vivo ﬁring activity recordings in DA neurons from NoSD and SD mice (51/38 mice). (c) SD increases
AMPA.R/NMDA.R ratio assessed in VTA slices ex vivo. Inset: sample current traces recorded in DA neurons from NoSD and SD mice (4/4 mice).
(d) The in vivo effects of acute intravenous nicotine (Nic) injection on DA ﬁring frequency are reduced in SD mice when compared to NoSD WT
mice (37/35 neurons; 27/25 mice). Inset left: Comparison of the mean± s.e.m. of increased variation from baseline in ﬁring rate in NoSD and
SD mice. (Inset right) ﬁring activity sample trace of a DA cell recorded from a NoSD and SD mice before and after nicotine injection (dashed
vertical red line). (e) Measurements of [3H]-epibatidine (left), [125I]-α-Bungarotoxin (middle) and [3H]-Hemicholinium (right) binding sites,
performed on isolated VTA P2 fractions prepared from NoSD and SD mice (24/24 mice), suggest an upregulation of β2* nicotinic acetylcholine
receptors (nAChRs) and an increased cholinergic tone in the VTA. Data are presented as mean± s.e.m., *Po0.05, **Po0.01 and ***Po0.01.
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this scenario, we treated mice with chronic nicotine in the
drinking water, and then combined it with a subthreshold defeat
(SubSD) paradigm (Figure 3a).25 We observed that SubSD
triggered social aversion in mice chronically pretreated with
nicotine, whereas it was ineffective in vehicle (saccharin)-
pretreated mice (Figure 3b). Chronic nicotine treatment per se
can induce enduring changes in VTA DA ﬁring and bursting events
(Figure 3c and Supplementary Figure S4b), and can also markedly
impair DA neurons activation in response to a subsequent
intravenous nicotine injection (Figure 3d). This prevents us from
measuring any putative additive effects of SubSD at the cellular
level in an attempt to understand the nicotine-stress interplay. To
circumvent this issue, mice were challenged by acute, and not
chronic, nicotine. WT mice were subjected to SubSD and
Figure 2. α7*nAChRs are required for social defeat (SD)-induced neurobehavioral adaptations. (a) Defeated (SD) α7β2 nicotinic acetylcholine
receptors (nAChRs) knockout (KO) mice do not exhibit social avoidance. (b) Chronic stress fails to increase ventral tegmental area (VTA)
dopamine (DA) neurons ﬁring and bursting activity in α7β2 KO mice (7/12 mice). (c) Time course of the mean± s.e.m. variation from baseline
of ﬁring rate in α7β2 nAChRs KO mice control (NoSD) and following SD (7/12 mice). Bottom: comparison of the mean± s.e.m. of increased
variation from baseline in ﬁring frequency (left) and %SWB (right) in undefeated (NoSD) and defeated (SD) mice (7/12 mice). (d) Social
interaction assessed in NoSD and SD mice that received during 10 days chronic treatment with an α7 nAChRs antagonist (methyllycaconitine,
MLA) or a β2* nAChRs antagonist (dihydro-β-erythroidine, DHβE) before each daily SD episodes. (e) Social interaction assessed in NoSD and SD
mice that received an acute injection of an α7 nAChRs antagonist (MLA) or a β2* nAChRs antagonist (DHβE) before the social interaction test.
Data are presented as mean± s.e.m., *Po0.05, **Po0.01 and ***Po0.01.
Stress and nicotine detrimental interplay
C Morel et al
4
Molecular Psychiatry (2017), 1 – 9
immediately after received an acute systemic i.p. injection of
saline or nicotine (0.5 mg kg− 1). As depicted in Figure 3e,
concomitant administration of acute nicotine with SubSD
increased DA neurons excitability in vitro. Altogether, these results
suggest that a short-lived stress episode primes VTA DA neurons,
and that nicotine exposure exacerbates its magnitude, therefore
constituting a risk factor for maintenance of cellular maladapta-
tions at the basis of affective disorders.
The potentiating effect of nicotine may reﬂect a gating
inﬂuence over information ﬂow within the DA system triggered
by a moderate stress. We thus next tested whether this
potentiation of nicotine effect can be recapitulated by activating
only a speciﬁc nAChRs subtype. α7 nAChRs have often been
involved in attentional functions and associative processes30 that
are likely to be engaged during the expression of social aversion.
Therefore, to probe for a speciﬁc involvement of α7* nAChRs in
this process, we employed PNU-120596, an α7* nAChRs selective
positive allosteric modulator.31,32 In WT mice primed by SubSD,
acute systemic PNU-120596 produced cellular changes of VTA DA
neurons (Figures 4a–c) that are comparable to neuroadaptations
induced by SD. Indeed, VTA DA neurons of SubSD mice pre-
treated with PNU-120596 exhibited increased in vitro excitability
and AMPA.R/NMDA.R ratio (Figures 4a and b, respectively), as well
as increased in vivo ﬁring frequency and bursting activities
(Figure 4c and Supplementary Figure S4c). As increases in DA
neurons activity is a prerequisite for the manifestations of
behavioral aspect of social stress,24,25 we would expect that
PNU-120596 precipitate behavioral changes in SubSD mice.
Indeed, systemic administration of PNU-120596 before SubSD,
promoted a marked social aversion (Figure 4d). It is worth noting
that PNU-120596 alone, at the dose used, did not induce changes
in locomotor activity (Supplementary Figure S5b), nor did it show
pro-depressant activity in the forced swim test (Supplementary
Figure S6). In contrast, a systemic injection before SubSD of
NS9283, a β2*nAChR-selective positive allosteric modulator,33 did
not induce social avoidance behavior (Supplementary Figure S7).
This demonstrates a speciﬁc role of α7* nAChRs in the expression
of social avoidance induced by social stress.
Our results suggest that nicotine exposure or activation of α7
nAChRs, can increase sensitivity to stress and promote long-lasting
cellular and behavioral changes. However, due to the fact that we
used systemic administration of drugs and the widespread
expression of this nAChR subtype in the brain, it is not possible
to relate these ﬁndings with a direct effect on the DA system. To
ascertain the speciﬁc impact of nAChRs in the VTA as a minimal
requirement to promote social avoidance, we used local infusion
of drugs through implanted cannulas (Figure 5). Cannulated WT
mice were given a single infusion of vehicle, PNU-120596 or
nicotine within the VTA combined with a moderate acute stress.
Concomitant administration of nicotine or PNU-120596 with
Figure 3. Nicotine exacerbates behavioral and cellular outcomes of social stress in wild-type (WT) mice. (a) Schematic showing chronic
nicotine (Nic) treatment followed with a subthreshold social defeat stress (SubSD) paradigm. (b) SubSD triggers social aversion in mice
chronically treated with nicotine but not with saccharin (Sacch; right). (c) Firing rate and percentage of spikes within bursts (%SWB; right
panel) of ventral tegmental area (VTA) dopamine (DA) cells recorded in vivo are increased in mice chronically treated with nicotine in the
drinking water but not with saccharin (5/5 mice). (d) The in vivo effects of acute intravenous nicotine injection on DA ﬁring frequency are
reduced in chronically nicotine-treated mice (Sacch+Nic) when compared to saccharin-treated WT mice (17/10 neurons; 5/5 mice). (e)
Excitability of VTA DA cells in mice that received systemic saline or nicotine (0.5 mg kg− 1) with or without exposure to SubSD. Right:
representative voltage traces from recorded neurons (Naive Veh: 3, Naive Nicotine: 4, SubSD Veh: 5, SubSD Nicotine 5 mice). Data are
presented as mean± s.e.m., *Po0.05, **Po0.01 and ***Po0.001.
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SubSD triggered a marked social aversion (Figure 5), which
therefore clearly implicates nAChRs in the VTA as mediators of
stress outcomes.
DISCUSSION
We have demonstrated that chronic social stress exposure
modiﬁes VTA nicotinic systems, a necessary condition for stress
effects to occur and which requires a dual role of α7 and β2*
nAChRs during the development and expression of the maladap-
tations. Conversely, we showed that nicotine potentiates stress
outcomes, and that the effect of nicotine can be recapitulated by
positively modulating α7 nAChRs function within the VTA. Overall,
although several studies have described depression as a
consequence of nicotine withdrawal, we here identify nicotine
exposure per se as a risk factor for the development of stress-
related disorders, independent of the withdrawal. This is a novel
perspective that helps unravel the complex relationship between
chronic stress exposure and nicotine addiction.
SD modiﬁes nicotine-evoked responses
Mice exposed to SD develop marked avoidance of social contacts
and exhibit several features that are reminiscent of human
depression.34 The neuronal circuits that underpin stress effects are
complex and far from being understood, but an increasing body
of literature strongly supports a pivotal role of the DA reward
system.23,24,26,34 SD triggers pronounced increases in VTA DA
neuron spontaneous activity, which is causally associated with
anhedonia and social aversion. Pre-exposure to stress is also well
acknowledged to facilitate self-administration and precipitate
relapse, and this is proposed to rely on changes of VTA DA
neurons activity.3,35 Activation of DA neurons and subsequent
release of DA in terminal ﬁelds are required for most drugs of
abuse reinforcing and rewarding effects to take place.36,37
Consequently, dysregulation of DA neurons activity by stress
affects subsequent drug responding. For example, acute restraint
stress in rats increases ethanol self-administration and this
correlates with an abolished ethanol-induced increase in DA
neurons ﬁring.38 Here we clearly show that chronic nicotine
administration or chronic social stress blunts the ability of nicotine
to activate VTA DA neurons. This could reﬂect a remodeling of
inhibitory and excitatory local connectivity in the VTA. Stress and
nicotine have been shown to decrease long-term potentiation of
inhibitory synapses onto VTA DA neurons.39 In addition, rewarding
and aversive stimuli trigger a strengthening of excitatory synapses
onto DA neurons, marked by an increase in AMPA.R/NMDA.R
ratio.40,41 Thus the net effect of abused drugs and stress is an
Figure 4. α7* nAChRs activation promote stress sensitization. (a) Left panel: subthreshold social defeat (SubSD) combined with intraperitoneal
(i.p.) drug injection paradigm. Right panel: PNU-120596, α7* selective agonist, treatment concomitant with SubSD causes a signiﬁcant increase
in ventral tegmental area (VTA) dopamine (DA) excitability measure ex vivo, (b) increase in AMPA/NMDA receptor ratio (Naive Veh: 3, Naive
PNU: 4, SubSD Veh: 4, SubSD PNU 4 mice), and (c) in vivo ﬁring (Hz) and bursting (% SWB) activity (NoSD Veh: 7, NoSD PNU: 4, SubSD Veh: 8,
SubSD PNU 7 mice). (d) Social interaction after SubSD assessed in mice that received an acute injection of PNU-120596 (PNU). PNU
administered concomitantly to SubSD promoted social aversion. Data are presented as mean± s.e.m., *Po0.05, **Po0.01 and ***Po0.01.
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enhanced activity of VTA DA neurons, potentially contributing to
comorbidities.35 However, more than that, our result suggests a
very speciﬁc interplay between stress and nicotine. Nicotine
response is modiﬁed in stressed animals, because exposure to
stress changes the primary substrate underlying nicotine
response, that is, both cholinergic tone and nAChRs expression
in the VTA. We revealed distinct key roles of β2* and α7* nAChRs
during the development and the expression phases of stress-
induced social aversion, respectively. From a potential therapeutic
point of view, targeting α7 nAChRs may be more relevant to
achieve stress relief.
Our work thus establishes a direct link between stress and
nicotinic system, which could explain why stress-related diseases
constitute a high-risk factor for nicotine addiction. We have
previously shown that the sensitivity of VTA DA cells to nicotine-
induced increase of activity determines the reinforcing dose of
nicotine.18 The reduced response to nicotine exposure of VTA DA
cells following SD may explain the high rates of tobacco
consumption in stressed people or subjects suffering from mood
disorders.
Nicotine exposure modiﬁes stress susceptibility
Stress/addiction relationship is often viewed in a unidirectional
way. Although it is well-known that stress increases tobacco
consumption and maintenance, other evidence suggests that pre-
exposure to nicotine can be an important factor to develop mood
disorders.7 Our results strongly implicate modiﬁcations of the
dopaminergic system. Nicotine exposure is known to regulate DA
functions. This effect can be direct through nicotine action on
nAChRs located within the dopaminergic system,12 or indirect
through, for example, recruitment of neuroendocrine systems.42
Nicotine activates the hypothalamo-pituitary adrenal axis by
primarily acting on neurons of the nucleus tractus solitarius
projecting to the hypothalamus, which ultimately leads to the
release of glucocorticoids hormones by the adrenal glands in both
rodents and humans.43,44 Glucocorticoids can then strengthen
excitatory transmission onto VTA DA neurons.41 We here
demonstrate that nicotine by itself can increase stress suscept-
ibility by amplifying acute stress effects. This is likely to be
independent of hypothalamo-pituitary adrenal axis activation, as
this effect can be replicated by local nicotine injection directly in
the VTA.
SubSD is not sufﬁcient to trigger social aversion in naive mice;
however, it primes the dopaminergic system in an additive way to
external challenges such as addictive substances. Concomitant
nicotine and SubSD exposure trigger social aversion, in a similar
manner that SD, by increasing DA cells activity. This rapid onset of
the symptoms is much the same as the one observed with a
selective optogenetic activation of DA neurons immediately after
SubSD.25 Our results also demonstrated that either systemic or
local VTA PNU-120596 exposure during SubSD is sufﬁcient to
trigger a marked social aversion. This differs from direct
optogenetic activation of VTA DA neurons. Indeed, PNU-120596
is a positive allosteric modulator for α7*nAChRs, which per se does
not directly increase VTA DA cells activity. The observed cellular
and behavioral changes in the SubSD paradigm therefore reﬂect a
change in endogenous acetylcholine release that is revealed by
PNU-120596 administration. This is in accordance with the
increase in [3H]hemicholinium binding, which suggests a marked
change in cholinergic tone in the VTA after stress. This result
suggests that cholinergic inputs to the VTA may constitute a signal
for stress susceptibility, but more importantly, tightly links the
susceptibility proﬁle with nicotinic systems in the VTA. As α7
nAChRs facilitate stress impact on VTA DA neurons and are
implicated in associative processes engaged in social avoidance,
preventing their activation could counteract stress outcomes, and
should be considered as a promising therapeutic target for
depression.
Positive and negative salience in the VTA
In the SubSD paradigm, nicotine can promote social aversion. This
gives the apparent paradox of a reinforcing substance that
potentiates an aversive event. If midbrain DA neurons activation
has long been associated with the processing of rewards, several
studies have shown that they also have a role in signaling
negative valence. Indeed, aversive stimuli including footpinch,
noxious footshock or forced swim in cold water signiﬁcantly affect
DA neurons activity.40,45,46 This illustrates the complexity and
multifunctional role of VTA DA neurons.47 SubSD per se does not
affect excitability of VTA DA neurons, but overall this aversive
stimulus is likely to initiate cellular processes affecting DA neurons
homeostasis, which will consequently facilitate the action of
further salient events such as nicotine intake. Hence, concomitant
nicotine administration can strengthen an aversive stimulus by its
action on DA neurons that have been previously primed by this
mild stressor.
Positive and negative valence stimuli also induce similar
changes in both VTA DA cells dynamics and synaptic plasticity.
Glutamatergic inputs onto DA neurons are potentiated when
animals are treated with abused substances such as cocaine or
nicotine.48,49 In addition to a direct action on VTA nAChRs
localized on DA and GABA neurons, nicotine, via presynaptic α7
nAChRs located on glutamatergic terminals, increases VTA
glutamate concentration and can induce long-lasting potentiation
of excitatory neurotransmission.50,51 In addition, a single in vivo
administration of nicotine, via both β2* and α7 nAChRs, increases
AMPA.R/NMDA.R ratio by enhancing GluA1-containing AMPA
receptors at post-synaptic sites.49 Similar cellular outcomes are
also produced by acute aversive stimuli via an enhancement in
AMPA receptor function.40,52 Here we show that chronically
stressed mice present a large increase in AMPA.R/NMDA.R ratio,
however further studies will be necessary to determine if it reﬂects
pre- or post-synaptic adaptations and address whether this
modiﬁcation share the same molecular mechanisms as those
seen in acute treatment with abused substances or aversive
stimuli.
Figure 5. Local activation of nAChRs in the VTA is a minimal
requirement to promote social avoidance. WT mice were implanted
with cannulas on the VTA and allow 1 week to recover. On the day of
the experiment, mice were infused with PNU-120596 (1.2 ng per
site) or nicotine (100 ng per site) and subjected to SubSD protocol.
Concomitant intra-VTA PNU-120596 or nicotine and SubSD treat-
ment resulted in signiﬁcant social aversion. Data are presented as
mean± s.e.m., *Po0.05 and **Po0.01.
Stress and nicotine detrimental interplay
C Morel et al
7
Molecular Psychiatry (2017), 1 – 9
These points emphasize the complexity of the role of VTA DA
neurons in motivational processes and add evidence against a
simplistic view of VTA DA cell function. Parallel synaptic and
cellular changes seen after drug exposure and stress may provide
a reason why acute stressors precipitate drug seeking. In this line,
we show here that an acute stress event combined with nicotine or
an α7 nAChRs positive modulator is sufﬁcient to induce changes in
ﬁring activity and glutamatergic plasticity that resemble those of
chronic stress or exposure to abused substances.
Nicotine and e-cigarettes
Our data also indicate that acute and chronic nicotine, which is
delivered by tobacco smoke or e-cigarettes, could exacerbate the
effects of social stress and thus increase the susceptibility to
develop stress-related mood disorders. One of the major aims of
public health policy is to reduce harm associate with smoking.
E-cigarette is viewed as a safer way to provide smokers with
nicotine, the addictive component, while sparing exposure to
other chemical constituents of tobacco smoke that are responsible
for a signiﬁcant portion of the harm caused by smoking. Our work
suggests that nicotine by itself can have important impact on
mood dysregulation and should be manipulated with caution.
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